FDA Will Talk 3-D Printing At October Workshop
This article was originally published in The Gray Sheet
Executive Summary
The Oct. 8-9 workshop will serve as a forum for FDA to collect public input on technical assessments that should be considered for 3-D printed devices to “provide a transparent evaluation process for future submissions.”
You may also be interested in...
FDA Tackles 3-D Printing Considerations In Draft Guidance
A draft guidance issued by FDA on additive manufacturing, or 3-D printing, of medical devices is meant to be a starting point for an industry that is growing exponentially. The document outlines recommendations on topics such as device design, software considerations and material testing requirements.
Report: Boom In 3D-Printed Medical Devices By 2022
A new market report estimates the global health-care revenue from 3D-printed medical devices is likely to grow to almost $3 billion by 2022. FDA has a keen interest in understanding how to oversee production of 3D-printed devices that can be made anywhere, and device-makers are interested in the technology to develop products personalized to patients.
Report: Boom In 3D-Printed Medical Devices By 2022
A new market report estimates the global health-care revenue from 3D-printed medical devices is likely to grow to almost $3 billion by 2022. FDA has a keen interest in understanding how to oversee production of 3D-printed devices that can be made anywhere, and device-makers are interested in the technology to develop products personalized to patients.